UGYO17017 / MD Anderson / Richard Moore
Research Question:
Can the blood test, CA-125 be helpful in the early detection of ovarian cancer in
women who are at low risk?
Basic Study Information
Purpose:
The goal of this clinical research study is to evaluate a method involving 4 blood
tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that
may be helpful in the early detection of ovarian cancer in women who are at low risk.
Location: Cancer Center
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT00539162?term=ID01-022&rank=1
Study Reference #: UGYO17017
Lead Researcher (Principal Investigator)
Lead Researcher:
Richard Moore
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search